T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis

INTRODUCTION: T-614 is a novel oral antirheumatic agent for the treatment of rheumatoid arthritis. Whether it has immunomodulatory or disease-modifying properties and its mechanism of action are largely undetermined. METHODS: Rats with collagen-induced arthritis (CIA) were treated with T-614 (5 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Fang, Lü, Liang-jing, Fu, Qiong, Dai, Min, Teng, Jia-lin, Fan, Wei, Chen, Shun-le, Ye, Ping, Shen, Nan, Huang, Xin-fang, Qian, Jie, Bao, Chun-de
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656239/
https://www.ncbi.nlm.nih.gov/pubmed/19019215
http://dx.doi.org/10.1186/ar2554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656239/
https://www.ncbi.nlm.nih.gov/pubmed/19019215
http://dx.doi.org/10.1186/ar2554

Ejemplares similares